Search Results - Drugs
Suggested Topics within your search.
Suggested Topics within your search.
- Neoplasms
- drug therapy 171
- Cancer 132
- Antineoplastic Agents 93
- therapy 78
- Antineoplastic agents 73
- Chemotherapy 71
- therapeutic use 70
- genetics 63
- Treatment 53
- methods 45
- Precision Medicine 38
- pharmacology 37
- Genetic aspects 34
- Immunotherapy 33
- complications 32
- Personalized medicine 30
- prevention & control 27
- metabolism 26
- immunology 25
- Drug Delivery Systems 22
- Molecular Targeted Therapy 22
- Drug development 21
- Drugs 21
- Pharmacogenetics 18
- Therapeutic use 18
- drug effects 18
- Drug Discovery 17
- Drug delivery systems 17
- Pain 17
-
1
Transporters in drug delivery
Published 2022Table of Contents: “…Contents: Biotransporters in drug delivery -- Classification of transporters -- P-glycoprotein transporters -- Transporters for cancer therapy -- Solute carrier transporters -- Facilitative glucose transporters -- The substrates and inhibitors of different transporters -- Effect of transporters in drug delivery -- Pharmacological applications.…”
Get full text
Series
Electronic Video -
2
Transporters in drug delivery
Published 2022Table of Contents: “…Contents: Biotransporters in drug delivery -- Classification of transporters -- P-glycoprotein transporters -- Transporters for cancer therapy -- Solute carrier transporters -- Facilitative glucose transporters -- The substrates and inhibitors of different transporters -- Effect of transporters in drug delivery -- Pharmacological applications.…”
Get full text
Series
Electronic Video -
3
Development of a cancer drug
Published 2022Table of Contents: “…Contents: Requirements for drug approval in the U.S. -- Legal evolution of drug approval -- The FDA and oncology drugs -- Clinical trial phases -- The effectiveness requirement -- Traditional and new approaches to trial design -- Types of controls -- Targeted therapies -- Companion diagnostics -- Endpoints for oncology trials -- Types of drug approval -- New drug application (NDA) -- Biomarkers -- FDA reviews and approvals.…”
Get full text
Series
Electronic Video -
4
Drug delivery for cancer therapeutics
Published 2021Table of Contents: “…Contents: Cancer therapeutics -- Drug delivery mechanisms -- Drug development -- Liposomes -- Nanoparticles -- Nanotechnology -- Nanotoxicology -- Niosomes -- Dendrimers -- Micelles -- Routes of drug delivery.…”
Get full text
Series
Electronic Video -
5
Need for drug delivery systems part 2 /
Published 2019Table of Contents: “…Contents: The need for delivery system in oncology -- Lipid-based nanotechnologies: a clinical reality -- Improving biodistribution and pharmacokinetics and safety -- Improving therapeutic outcome upon increasing drug release at target organ -- Targeting tumor microenvironment at two different cell levels -- Improving formulation.…”
Get full text
Series
Electronic Video -
6
Need for drug delivery systems part 2 /
Published 2019Table of Contents: “…Contents: The need for delivery system in oncology -- Lipid-based nanotechnologies: a clinical reality -- Improving biodistribution and pharmacokinetics and safety -- Improving therapeutic outcome upon increasing drug release at target organ -- Targeting tumor microenvironment at two different cell levels -- Improving formulation.…”
Get full text
Series
Electronic Video -
7
Drug delivery for cancer therapeutics
Published 2021Table of Contents: “…Contents: Cancer therapeutics -- Drug delivery mechanisms -- Drug development -- Liposomes -- Nanoparticles -- Nanotechnology -- Nanotoxicology -- Niosomes -- Dendrimers -- Micelles -- Routes of drug delivery.…”
Get full text
Series
Electronic Video -
8
Development of a cancer drug
Published 2022Table of Contents: “…Contents: Requirements for drug approval in the U.S. -- Legal evolution of drug approval -- The FDA and oncology drugs -- Clinical trial phases -- The effectiveness requirement -- Traditional and new approaches to trial design -- Types of controls -- Targeted therapies -- Companion diagnostics -- Endpoints for oncology trials -- Types of drug approval -- New drug application (NDA) -- Biomarkers -- FDA reviews and approvals.…”
Get full text
Series
Electronic Video -
9
The mTOR kinase as a target for anti-cancer drugs
Published 2010Subjects: “…Neoplasms drug therapy.…”
Get full text
Series
Electronic Video -
10
The mTOR kinase as a target for anti-cancer drugs
Published 2010Subjects: “…Neoplasms drug therapy. 108882…”
Get full text
Series
Electronic Video -
11
The mTOR kinase as a target for anti-cancer drugs
Published 2010Subjects: “…Neoplasms drug therapy. 108882…”
Get full text
Series
Electronic Video -
12
Drug metabolizing enzymes in cancer therapeutics
Published 2018Table of Contents: “…Contents: Drug metabolism -- Classification of drug metabolizing enzymes (DMEs) -- Clinical significance of DMEs in cancer therapeutics -- Drug delivery -- Drug resistance -- Interindividual variability and precision oncology.…”
Get full text
Series
Electronic Video -
13
Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /
Published 2009Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series
Electronic Video -
14
Drug metabolizing enzymes in cancer therapeutics
Published 2018Table of Contents: “…Contents: Drug metabolism -- Classification of drug metabolizing enzymes (DMEs) -- Clinical significance of DMEs in cancer therapeutics -- Drug delivery -- Drug resistance -- Interindividual variability and precision oncology.…”
Get full text
Series
Electronic Video -
15
Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /
Published 2009Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series
Electronic Video -
16
Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /
Published 2009Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series
Electronic Video -
17
Drug metabolizing enzymes in cancer therapeutics
Published 2018Table of Contents: “…Contents: Drug metabolism -- Classification of drug metabolizing enzymes (DMEs) -- Clinical significance of DMEs in cancer therapeutics -- Drug delivery -- Drug resistance -- Interindividual variability and precision oncology.…”
Get full text
Series
Electronic Video -
18
Pain and symptom control in palliative care new ways to think about old drugs /
Published 2009Subjects: “…Neoplasms drug therapy.…”
Get full text
Series
Electronic Video -
19
Pain and symptom control in palliative care new ways to think about old drugs /
Published 2009Subjects: “…Neoplasms drug therapy. 113204…”
Get full text
Series
Electronic Video -
20
Pain and symptom control in palliative care new ways to think about old drugs /
Published 2009Subjects: “…Neoplasms drug therapy. 113204…”
Get full text
Series
Electronic Video